With our unique expertise and consulting excellence
your project in Russia will run like clockwork.

The share of FDA/EMA approved drugs studied in international clinical trials placed partially in Russia has reached 65% in 2013. Russian drug development market is also growing rapidly.

Lenpharma is dedicated to providing quality consulting services and taking the role of a strategic guide to your CRO, Pharmaceutical or Biotech company, ensuring smooth and successful entry to the emerging Russian market.

We are a team of professionals with many years of experience in this challenging industry and a sharp focus on the following services:

  1. Regulatory clinical study approval, import/export licenses
  2. Medical Affairs in Russia and Eastern Europe
  3. QA & QC in Russia & internationally
  4. Trainings ICH GCP, site auditing, SOP
  5. Investigators’ Meeting organization in Russia
  6. Storage of laboratory kits, equipment & study related materials